Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning

Graft-versus-host disease-free, relapse-free survival (GRFS) is a useful composite end point that measures survival without relapse or significant morbidity after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We aimed to develop a novel analytical method that appropriately handles...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasaki, Makoto, Kanda, Junya, Arai, Yasuyuki, Kondo, Tadakazu, Ishikawa, Takayuki, Ueda, Yasunori, Imada, Kazunori, Akasaka, Takashi, Yonezawa, Akihito, Yago, Kazuhiro, Nohgawa, Masaharu, Anzai, Naoyuki, Moriguchi, Toshinori, Kitano, Toshiyuki, Itoh, Mitsuru, Arima, Nobuyoshi, Takeoka, Tomoharu, Watanabe, Mitsumasa, Hirata, Hirokazu, Asagoe, Kosuke, Miyatsuka, Isao, An, Le My, Miyanishi, Masanori, Takaori-Kondo,, Akifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043925/
https://www.ncbi.nlm.nih.gov/pubmed/34933327
http://dx.doi.org/10.1182/bloodadvances.2021005800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043925/
https://www.ncbi.nlm.nih.gov/pubmed/34933327
http://dx.doi.org/10.1182/bloodadvances.2021005800

Ejemplares similares